Program in Anemia Signaling Research, Division of Nephrology, Program in Membrane Biology, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
Hepatology. 2019 Dec;70(6):1986-2002. doi: 10.1002/hep.30780. Epub 2019 Aug 13.
A failure of iron to appropriately regulate liver hepcidin production is central to the pathogenesis of hereditary hemochromatosis. SMAD1/5 transcription factors, activated by bone morphogenetic protein (BMP) signaling, are major regulators of hepcidin production in response to iron; however, the role of SMAD8 and the contribution of SMADs to hepcidin production by other systemic cues remain uncertain. Here, we generated hepatocyte Smad8 single (Smad8 ;Alb-Cre ), Smad1/5/8 triple (Smad158;Alb-Cre ), and littermate Smad1/5 double (Smad15;Alb-Cre ) knockout mice to investigate the role of SMAD8 in hepcidin and iron homeostasis regulation and liver injury. We found that Smad8;Alb-Cre mice exhibited no iron phenotype, whereas Smad158;Alb-Cre mice had greater iron overload than Smad15;Alb-Cre mice. In contrast to the sexual dimorphism reported for wild-type mice and other hemochromatosis models, hepcidin deficiency and extrahepatic iron loading were similarly severe in Smad15;Alb-Cre and Smad158;Alb-Cre female compared with male mice. Moreover, epidermal growth factor (EGF) failed to suppress hepcidin in Smad15;Alb-Cre hepatocytes. Conversely, hepcidin was still increased by lipopolysaccharide in Smad158;Alb-Cre mice, although lower basal hepcidin resulted in lower maximal hepcidin. Finally, unlike most mouse hemochromatosis models, Smad158;Alb-Cre developed liver injury and fibrosis at 8 weeks. Liver injury and fibrosis were prevented in Smad158;Alb-Cre mice by a low-iron diet and were minimal in iron-loaded Cre mice. Conclusion: Hepatocyte Smad1/5/8 knockout mice are a model of hemochromatosis that encompasses liver injury and fibrosis seen in human disease. These mice reveal the redundant but critical role of SMAD8 in hepcidin and iron homeostasis regulation, establish a requirement for SMAD1/5/8 in hepcidin regulation by testosterone and EGF but not inflammation, and suggest a pathogenic role for both iron loading and SMAD1/5/8 deficiency in liver injury and fibrosis.
铁不能适当调节肝脏铁调素的产生是遗传性血色素沉着症发病机制的核心。SMAD1/5 转录因子被骨形态发生蛋白 (BMP) 信号激活,是铁反应中铁调素产生的主要调节剂;然而,SMAD8 的作用以及 SMADs 对其他全身信号引起的铁调素产生的贡献仍不确定。在这里,我们生成了肝细胞 Smad8 单敲除 (Smad8;Alb-Cre)、Smad1/5/8 三敲除 (Smad158;Alb-Cre) 和同窝 Smad1/5 双敲除 (Smad15;Alb-Cre) 小鼠,以研究 SMAD8 在铁调素和铁稳态调节及肝损伤中的作用。我们发现 Smad8;Alb-Cre 小鼠没有铁表型,而 Smad158;Alb-Cre 小鼠的铁过载比 Smad15;Alb-Cre 小鼠更严重。与野生型小鼠和其他血色素沉着症模型报告的性别二态性相反,Smad15;Alb-Cre 和 Smad158;Alb-Cre 雌性小鼠的铁调素缺乏和肝外铁负荷与雄性小鼠相似严重。此外,表皮生长因子 (EGF) 未能抑制 Smad15;Alb-Cre 肝细胞中的铁调素。相反,脂多糖仍能增加 Smad158;Alb-Cre 小鼠的铁调素,尽管基础铁调素较低导致最大铁调素较低。最后,与大多数小鼠血色素沉着症模型不同,Smad158;Alb-Cre 小鼠在 8 周时发生肝损伤和纤维化。低铁饮食可预防 Smad158;Alb-Cre 小鼠的肝损伤和纤维化,而在铁负荷 Cre 小鼠中则很少见。结论:肝细胞 Smad1/5/8 敲除小鼠是一种涵盖人类疾病中所见肝损伤和纤维化的血色素沉着症模型。这些小鼠揭示了 SMAD8 在铁调素和铁稳态调节中的冗余但关键作用,确定了 SMAD1/5/8 在睾酮和 EGF 但不是炎症调节铁调素中的作用,并且表明铁负荷和 SMAD1/5/8 缺乏在肝损伤和纤维化中都具有致病性。